3171 results for «3358»

Filter By

3171 results

Rapid-fire clinical cases: session 2

27 Nov 2022 – From PCR London Valves 2022

Discover in the same PCR LV 2022 session a TAVI for pure aortic regurgitation in degenerated aortic homograft, an embolised Myval transcatheter heart valve to AAA, or a challenging ViV TAVI, and much more!

Rapid-fire clinical cases: session 2

TAVI: Late-Breaking Trials and Innovations

27 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions, and learn more about the early safety and performance of the Vienna TAVI system, the new-generation transcatheter aortic valve platforms performance in native pure aortic regurgitation, and more!

TAVI: Late-Breaking Trials and Innovations

Rapid-fire abstracts: session 4

27 Nov 2022 – From PCR London Valves 2022

In this PCR LV 2022 session dedicated to TAVI, take advantage of the 7 abstracts to learn more about the impact of TAVI for pure regurgitation on the severity of concomitant mitral regurgitation, the deformation of transcatheter heart valve and haemodynamics after aortic ViV, and much...

Rapid-fire abstracts: session 4

Ensuring optimal TAVI outcomes - LIVE case

27 Nov 2022 – From PCR London Valves 2022

A 75-year-old female with diabetes and history of ischemic stroke 5 years ago presents a symptomatic severe aortic valve stenosis in a small annulus.
After pre-dilatation (18 mm balloon), the operators implant an Acurate neo2 23 mm with a sentinel cerebral embolic protection device. Watch them perform...

Ensuring optimal TAVI outcomes

Hot TAVI topics - Emerging indications

27 Nov 2022 – From PCR London Valves 2022

Consult this session on hot TAVI topics to learn more about the under-treatment problem of patients with aortic valve disease, the rationale behind emerging TAVI indications and ongoing trials, as well as the nuances of patient selection and the key role of cardiac imaging in identifying markers of...

Hot TAVI topics - Emerging indications

Primary mitral regurgitation: treatment options when the anatomy is complex

27 Nov 2022 – From PCR London Valves 2022

Take a look at these presentations to learn more about complex primary mitral regurgitation (and how to differentiate it from simple disease), to understand why it is complex and to know what the treatment options are.

Primary mitral regurgitation: treatment options when the anatomy is complex

Repair vs. replacement for the treatment of tricuspid valve disease

27 Nov 2022 – From PCR London Valves 2022

Watch this session on tricuspid valve disease to learn more about its current modes of treatment (including new and emerging devices), to understand which patients are the best candidates for this procedure and to explore the challenges that may be encountered during it.

Repair vs. replacement for the treatment of tricuspid valve disease

TAVI: emerging evidence

27 Nov 2022 – From PCR London Valves 2022

Through the 5 abstracts of this PCR LV 2022 session, follow the comparison between last-generation balloon and self-expandable TAVR for bicuspid aortic valve stenosis, and the comparison between multiple tools to assess the risk of mortality after TAVR, evaluate the impact of post-TAVI vascular complications, and...

TAVI: emerging evidence

TAVI challenges: session 1

27 Nov 2022 – From PCR London Valves 2022

Discover a series of TAVI challenges shared by your peers: a transfemoral TAVR through a severely tortuous and horizontal aorta in a morbidly obese patient, TAVI for pure non-calcified severe aortic regurgitation in a large annulus, peripheral access calcifications and more.

TAVI challenges: session 1

TMVR challenges

27 Nov 2022 – From PCR London Valves 2022

Challenges in this session of PCR LV 2022 include hybrid valve implantation for mitral annular calcification, transcatheter double-valve implantation complicated by mitral bioprosthesis migration, and transcatheter transseptal mitral valve implantation. Watch now to find out more!

TMVR challenges

Transcatheter primary mitral regurgitation repair and tricuspid replacement - LIVE case

28 Nov 2022 – From PCR London Valves 2022

  • Part 1: Primary MR repair (recorded case)
    An 89-year-old male with atrial fibrillation, severe primary MR (prolapse A1-A2) with a preserved LV function. The operators implant 1 Pascal ACE, on general anaesthesia, guided by TEE.
  • Part 2: Tricuspid valve in valve (Live case)
    A 52-year-old female, with diabetes and...
Transcatheter intervention for mitral and tricuspid valve disease: state of the art

Challenging scenarios: acute coronary obstruction

28 Nov 2022 – From PCR London Valves 2022

Discover some challenging case of acute coronary obstruction in these presentations, and learn more about the anatomical and procedural factors that predict this complication during TAVI, the available strategies for coronary protection during TAVI, as well as the leaflet laceration techniques to prevent TAVI-induced coronary obstruction.

Challenging scenarios: acute coronary obstruction

TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.

Top Late-Breaking Trials

CLASP II TR, TriBAND, bRIGHT: Late-Breaking Trials on tricuspid intervention

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions in this session: the CLASP II TR on transcatheter tricuspid valve repair, the TriBAND study one-year outcomes on transcatheter tricuspid annular reduction, and the bRIGHT trial on real-world outcomes for TEER.

Tricuspid - Late-Breaking Trials

Patient selection for tricuspid valve interventions

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the anatomical assessment of candidates for transcatheter tricuspid valve interventions, to understand the importance of detailed haemodynamic assessment in patients with severe tricuspid regurgitation and to discuss the predictors of clinical outcome after these interventions.

Patient selection for tricuspid valve interventions

Transcatheter dilatation of aorta coarctation in a 5-month-old baby - LIVE case

04 Mar 2023 – From AfricaPCR 2023

A 5-month-old baby girl with hypoplastic left heart syndrome was born at term (3 Kg) with associated large ASD secundum. A surgical repaired aortic arch with ASD and PDA closing was performed at 2 weeks old. At 5 months, she presented a re-coarctation of the aorta (65...

Coarctation of aorta, balloon angioplasty of recurrent coarctation following surgical repair

Transcatheter tricuspid valve interventions: outcomes

11 Mar 2023 – From PCR Imaging Valves Madrid 2023

Watch these presentations to learn how to better assess transcatheter tricuspid valve interventions results, to understand what are the endpoints after interventions as well as to learn what we can expect in future guidelines.

Transcatheter tricuspid valve interventions: outcomes

TAVI for complex valve

19 Feb 2023 – From PCR Tokyo Valves 2023

Join this session to discover TAVI challenges for complex valves. Gain insights into variations in TAVI patient treatment: bicuspid valve with atypical calcium chunk, balloon-expandable valve implantation, sinus sequestration, hybrid therapy and more!

Tips and tricks in valvular intervention

19 Feb 2023 – From PCR Tokyo Valves 2023

In this session, unlock advanced valvular intervention insights (in Japanese). Overcome challenges like aortic valve alignment failure, cardiogenic shock with LMTD and AS and unforseen low atrial septal puncture for successful, optimised procedures.

Selection of the 2023 best clinical cases

19 Feb 2023 – From PCR Tokyo Valves 2023

Explore the most outstanding clinical cases from PCR Tokyo Valves 2023, including a delayed left ventricular rupture after transcatheter edge-to-edge mitral valve repair and successful bailouts in transcatheter mitral valve repair.

Didn’t find what you were looking for?